H. Gill

Massey University

Health Outcomes Studied

• Enhanced Natural Killer Cell Tumoricidal Activity
• Increased Interferon-Alpha Production
• Increased PMN Cell Phagocytic Capacity

Papers (16)

• 2005
  Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.10.1016/J.IJFOODMICRO.2004.05.011
• 2005
  Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis.10.1016/J.IJFOODMICRO.2004.11.031
• 2002
  Dietary intake of Lactobacillus rhamnosus HN001 enhances production of both Th1 and Th2 cytokines in antigen-primed mice10.1007/s00430-002-0112-7
• 2002
  Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice.10.1111/J.1574-695X.2002.TB00603.X
• 2001Primary author
  Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN00110.1007/s004300100095
• 2001
  Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro.10.1016/S0168-1605(00)00398-6
• 2001
  Probiotic Treatment Using Bifidobacterium lactis HN019 Reduces Weanling Diarrhea Associated With Rotavirus and Escherichia coli Infection in a Piglet Model10.1097/00005176-200108000-00014
• 2001
  A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice10.1007/s430-001-8021-9
• 2001Primary author
  Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019.10.1093/AJCN/74.6.833
• 2001
  Systemic Immunity-Enhancing Effects in Healthy Subjects Following Dietary Consumption of the Lactic Acid Bacterium Lactobacillus rhamnosus HN00110.1080/07315724.2001.10719027
• 2000
  Dietary Bifidobacterium lactis (HN019) Enhances Resistance to Oral Salmonella typhimurium Infection in Mice10.1111/j.1348-0421.2000.tb02486.x
• 2000
  Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria.10.1016/S0278-6915(99)00154-4
• 2000
  Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice.10.1016/S0168-1605(00)00219-1
• 2000Primary author
  Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019).10.1017/S0007114500000210
• 2000
  Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses10.1038/sj.ejcn.1601093
• 2000
  Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019)10.1038/sj.ejcn.1600938